The effectiveness of vaginal progesterone in reducing preterm birth in high-risk patients diagnosed with short cervical length after 24 weeks: A retrospective cohort study

The effectiveness of vaginal progesterone in reducing preterm birth in high-risk patients diagnosed with short cervical length after 24 weeks: A retrospective cohort study

ObjectiveTo assess the impact of progesterone treatment on maternal and neonatal outcomes in women with a history of preterm birth and short cervical length diagnosed after 24 weeks of gestation.MethodsA retrospective cohort study included women with a history of preterm birth and a transvaginal son...

Full description

Bibliographic Details
Main Authors:	Danielle Luxenbourg, Shay Porat, Roberto Romero, Dror Raif Nesher, Rani Haj Yahya, Yishai Sompolinsky, Hila Hochler, Yossef Ezra, Doron Kabiri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Medicine
Subjects:	admission to neonatal intensive care unit prematurity preterm delivery preterm labor progesterone progestogen
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1130942/full

Similar Items

Comparing the efficacy of vaginal micronized progesterone gel and capsule for prevention of preterm birth in singleton pregnancies with short cervical length at midtrimester: an indirect comparison meta-analysis
by: Doron Kabiri, et al.
Published: (2023-07-01)

Maintenance Therapy by Vaginal Progesterone after Threatened Idiopathic Preterm Labor: A Randomized Placebo-Controlled Double-blind Trial
by: Seyede Hajar Sharami, et al.
Published: (2010-07-01)

Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM)
by: Jane E Norman, et al.
Published: (2018-06-01)

Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor
by: Bushra Ashraf
Published: (2019-09-01)

Progesterone supplementation for prevention of preterm labor: A randomized controlled trial
by: Moustafa Ibrahim, et al.
Published: (2010-01-01)

Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis protocol
by: Kimberley P. Williams, et al.
Published: (2021-05-01)

Effectiveness of Progestogens as Maintenance Tocolysis and Urogenital Cultures: Secondary Analysis of the PROTECT Trial
by: Lucrezia Pignatti, et al.
Published: (2020-07-01)

COMPARISON OF MICRONIZED PROGESTERONE (CYCLOGEST PESSARY) AND PLACEBO IN PREVENTION OF PRE-TERM BIRTH IN TERTIARY CARE HOSPITAL
by: Nighat Afridi, et al.
Published: (2020-12-01)

Vaginal versus intramuscular progesterone in the prevention of preterm labor and their effect on uterine and fetal blood flow
by: Azza A. Abd El Hameed
Published: (2012-09-01)

Micronized progesterone: several aspects of miscarriage prophylaxis
by: N A Osipova
Published: (2014-06-01)

Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine
by: Lucie Kolatorova, et al.
Published: (2022-07-01)

Comparison of the duration of pregnancy in administration of progesterone suppository and Duphaston tablet in pregnant women with preterm labor after stopping delivery process
by: Marzieh Lotfalizadeh, et al.
Published: (2019-12-01)

Progesterone: A Unique Hormone with Immunomodulatory Roles in Pregnancy
by: Raj Raghupathy, et al.
Published: (2022-01-01)

PROPHYLACTIC USE OF 17OH PROGESTERONE FOR PREVENTION OF PRETERM LABOUR IS EFFECTIVE
by: Rabia Sajjad, et al.
Published: (2020-08-01)

Progesterone Receptor Signaling in the Uterus Is Essential for Pregnancy Success
by: Dominique I. Cope, et al.
Published: (2022-04-01)

COMPARISON OF MICRONIZED PROGESTERONE (CYCLOGEST PESSARY) AND PLACEBO IN PREVENTION OF PRE-TERM BIRTH IN TERTIARY CARE HOSPITAL
by: Nighat Afridi, et al.
Published: (2020-12-01)

Progestagens in high-risk pregnancy. What we know today
by: N.Y. Pedachenko, et al.
Published: (2023-06-01)

Progesterone Gel and Placebo Prolonged Pregnancy More Effectively Than Intravenous Tocolysis Alone in Women with Preterm Labor
by: Ylva Vladic Stjernholm, et al.
Published: (2022-04-01)

The role of salivary progesterone and cervical length measurement in predicting risk of spontaneous preterm birth
by: Sara Oday, et al.
Published: (2021-06-01)

Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol
by: Joan T. Price, et al.
Published: (2017-07-01)

Role of vaginal progesterone on uterine artery Doppler changes in pregnant women at risk of preterm labor
by: Ibrahim M El-Maghraby, et al.
Published: (2022-01-01)

Progesterone, cervical cerclage or cervical pessary to prevent preterm birth: a decision-making analysis of international guidelines
by: Putora Katharina, et al.
Published: (2022-04-01)

Addressing Decision Making in Progesterone Treatment for History of Preterm Delivery
by: Jacqueline Zuponcic, et al.
Published: (2019-07-01)

Effects of female sex hormones on the development of atherosclerosis
by: Sung-Po Hsu, et al.
Published: (2020-01-01)

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
by: John C Stevenson, et al.
Published: (2020-12-01)

Association between the duration of progesterone supplementation treatment and premature neonates outcomes: A retrospective cohort study
by: Soudabeh Kazemi Aski, et al.
Published: (2023-11-01)

Effect of progesterone as maintenance tocolytic therapy on the prevention of recurrent preterm labor: a randomized clinical trial
by: Hajieh Borna, et al.
Published: (2007-03-01)

A Comparison between the Effects of Vaginal Suppository Progesterone vs. the Injection of 17-Alpha Hydroxyprogesterone Caproate on the Duration of Latent Phase After Controlled Threatened Preterm Labor
by: Fatemeh Mirzaei, et al.
Published: (2018-03-01)

Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial
by: Maud D. van Zijl, et al.
Published: (2017-09-01)

Maternal and Fetal Doppler Blood Flow Velocimetry Changes in the Management of Asymptomatic Preterm Labor With Vaginal Progesterone Tablet
by: Shirin Niromanesh, et al.
Published: (2018-06-01)

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes
by: Fatemeh Abdali, et al.
Published: (2018-01-01)

Key to Life: Physiological Role and Clinical Implications of Progesterone
by: Bernadett Nagy, et al.
Published: (2021-10-01)

Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
by: Jacques Donnez, et al.
Published: (2021-03-01)

Vaginal Progesterone Has No Diabetogenic Potential in Twin Pregnancies: A Retrospective Case-Control Study on 1686 Pregnancies
by: Klara Rosta, et al.
Published: (2020-07-01)

Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial
by: Ka Wang Cheung, et al.
Published: (2020-01-01)

Comparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical Trial
by: Afsar Sadat Tabatabaei Bafghi, et al.
Published: (2015-10-01)

Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?
by: Zhi Xia, et al.
Published: (2021-11-01)

Progestogens in menopausal hormone therapy
by: Małgorzata Bińkowska, et al.
Published: (2015-06-01)

Prevention of Preterm Birth with Progesterone
by: Gian Carlo Di Renzo, et al.
Published: (2021-09-01)

Effects of vaginal progesterone and placebo on preterm birth and antenatal outcomes in women with singleton pregnancies and short cervix on ultrasound: a meta-analysis
by: Limin Peng, et al.
Published: (2024-04-01)